Background and purpose: Recent investigations demonstrated a significant correlation between rectal dose-volume patterns and late rectal toxicity. The reduction of the DVH to a value expressing the probability of complication would be suitable. To fit different normal tissue complication probability (NTCP) models to clinical outcome on late rectal bleeding after external beam radiotherapy (RT) for prostate cancer. Patients and methods: Rectal dose-volume histograms of the rectum (DVH) and clinical records of 547 prostate cancer patients (pts) pooled from five institutions previously collected and analyzed were considered. All patients were treated in supine position with 3 o
The risk of radio-induced gastrointestinal (GI) complications is affected by several factors other t...
The rectum is known to display a dose-volume effect following high-dose 3D-conformal radiotherapy (3...
Rectal bleeding and faecal incontinence are serious injuries that men with prostate cancer who recei...
Purpose: To identify clinically relevant parameters predictive of late rectal bleeding derived from ...
Background and purpose: Curative radiotherapy for prostate cancer may lead to anorectal side effects...
International audienceDose escalation in prostate cancer is made possible due to technological advan...
The purpose of this study was to evaluate rectum motion during 3-Dimensional conformal radiation the...
Purpose: To study the impact of clinical predisposing factors on rectal normal tissue complication p...
PURPOSE: To assess the association between the dose distributions in the rectum and late Radiation T...
BACKGROUND AND PURPOSE: The Normal Tissue Complication Probability (NTCP) for rectum is usually defi...
PURPOSE: To analyze the reliability of different methods used in evaluating the risk of late rectal ...
Background and purpose: To fit an NTCP model including clinical risk factors to late rectal toxiciti...
The introduction of modern image-guided radiotherapy (IGRT) has given new insight regarding organ mo...
Background and Purpose: Associations between dose and rectal toxicity in prostate radiotherapy are g...
Purpose: This study aimed to assess the impact of radiation dose on rectal toxicity after salvage ex...
The risk of radio-induced gastrointestinal (GI) complications is affected by several factors other t...
The rectum is known to display a dose-volume effect following high-dose 3D-conformal radiotherapy (3...
Rectal bleeding and faecal incontinence are serious injuries that men with prostate cancer who recei...
Purpose: To identify clinically relevant parameters predictive of late rectal bleeding derived from ...
Background and purpose: Curative radiotherapy for prostate cancer may lead to anorectal side effects...
International audienceDose escalation in prostate cancer is made possible due to technological advan...
The purpose of this study was to evaluate rectum motion during 3-Dimensional conformal radiation the...
Purpose: To study the impact of clinical predisposing factors on rectal normal tissue complication p...
PURPOSE: To assess the association between the dose distributions in the rectum and late Radiation T...
BACKGROUND AND PURPOSE: The Normal Tissue Complication Probability (NTCP) for rectum is usually defi...
PURPOSE: To analyze the reliability of different methods used in evaluating the risk of late rectal ...
Background and purpose: To fit an NTCP model including clinical risk factors to late rectal toxiciti...
The introduction of modern image-guided radiotherapy (IGRT) has given new insight regarding organ mo...
Background and Purpose: Associations between dose and rectal toxicity in prostate radiotherapy are g...
Purpose: This study aimed to assess the impact of radiation dose on rectal toxicity after salvage ex...
The risk of radio-induced gastrointestinal (GI) complications is affected by several factors other t...
The rectum is known to display a dose-volume effect following high-dose 3D-conformal radiotherapy (3...
Rectal bleeding and faecal incontinence are serious injuries that men with prostate cancer who recei...